![]() Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. | ![]() PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. | NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | |
Founding Date | Founding Date 1981 | Founding Date 2002 | Founding Date 2006 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations Malvern, US HQ | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US |
Employees | Employees 9,9041% decrease | Employees 22 | Employees 91 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 340.9 m |
Financial | |||
Revenue (est.) | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) $10.8m (FY, 2021) | Revenue (est.) £48.7m (FY, 2025) |
Net income | Net income N/A | Net income ($131.1m) (FY, 2021) | Net income £7m (FY, 2025) |

PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
View companyNIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View company